Home LiteratureArticle Details
PMID: 11559670 Published · ppublish English Journal Article Review

Nitric oxide: an emerging role in cardioprotection?

Heart (British Cardiac Society) ·Vol. 86 ·No. 4 ·2001-10-00 ·Pages 368-72

Rakhit RD, Marber MS

Abstract

暂无摘要

MeSH Terms
Angina Pectoris/drug therapy Cardiovascular Agents/therapeutic use Free Radical Scavengers/therapeutic use Heart Diseases/metabolism,prevention & control Humans Myocardial Infarction/drug therapy Nitric Oxide/physiology,therapeutic use Nitric Oxide Donors/therapeutic use
Chemicals
Cardiovascular Agents Free Radical Scavengers Nitric Oxide Donors Nitric Oxide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rakhit R D
Waller Department of Cardiology, St Marys Hospital, Praed Street, London W2 1NY, UK. roby@rakhit.freeserve.co.uk
Marber M S
References (48)
48 references, click to expand
  1. Levels of nitric oxide in the heart after experimental myocardial ischemia.
    J Cardiovasc Pharmacol. 2001 Jan;37(1):55-63 PMID: 11152374
  2. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes.
    Circulation. 2001 May 29;103(21):2617-23 PMID: 11382733
  3. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
    Lancet. 1988 May 14;1(8594):1088-92 PMID: 2896919
  4. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion.
    Crit Care Med. 1991 Feb;19(2):244-52 PMID: 1846569
  5. The cell biology of acute myocardial ischemia.
    Annu Rev Med. 1991;42:225-46 PMID: 2035969
  6. Nitric oxide: physiology, pathophysiology, and pharmacology.
    Pharmacol Rev. 1991 Jun;43(2):109-42 PMID: 1852778
  7. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide.
    Circulation. 2000 Feb 1;101(4):439-45 PMID: 10653837
  8. Diastolic heart failure.
    Cardiovasc Res. 2000 Mar;45(4):813-25 PMID: 10728407
  9. Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes.
    Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1211-7 PMID: 10749716
  10. Adenosine preconditioning reduces both pre and postischemic arrhythmias in human myocardium.
    J Surg Res. 2000 May 15;90(2):191-6 PMID: 10792962
  11. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure.
    J Am Coll Cardiol. 2000 Sep;36(3):845-51 PMID: 10987609
  12. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
    Circulation. 2000 Oct 31;102(18):2276-81 PMID: 11056105
  13. Nitric oxide donors.
    Proc Soc Exp Biol Med. 2000 Dec;225(3):200-6 PMID: 11082214
  14. Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions.
    Biochim Biophys Acta. 2000 Dec 15;1524(2-3):203-11 PMID: 11113569
  15. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
    J Pharmacol Exp Ther. 1992 Feb;260(2):668-75 PMID: 1738117
  16. Nitric oxide attenuates cardiac myocyte contraction.
    Am J Physiol. 1993 Jul;265(1 Pt 2):H176-82 PMID: 8342632
  17. Pathological implications of nitric oxide, superoxide and peroxynitrite formation.
    Biochem Soc Trans. 1993 May;21(2):330-4 PMID: 8395426
  18. Nitric oxide biology: implications for cardiovascular therapeutics.
    Cardiovasc Res. 1994 Jan;28(1):25-30 PMID: 8111788
  19. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion.
    Circulation. 1994 May;89(5):2070-8 PMID: 7910117
  20. Nitric oxide mediated venodilator effects of nebivolol.
    Br J Clin Pharmacol. 1994 Sep;38(3):199-204 PMID: 7826820
  21. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
    Circulation. 1995 Mar 1;91(5):1545-51 PMID: 7867197
  22. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction.
    J Thorac Cardiovasc Surg. 1995 Jun;109(6):1146-54 PMID: 7776679
  23. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury.
    J Thorac Cardiovasc Surg. 1995 Aug;110(2):302-14 PMID: 7543634
  24. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.
    Lancet. 1996 Apr 27;347(9009):1151-5 PMID: 8609750
  25. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.
    Arch Biochem Biophys. 1996 Apr 15;328(2):309-16 PMID: 8645009
  26. Peroxynitrite-induced cardiac myocyte injury.
    Free Radic Biol Med. 1996;20(3):343-50 PMID: 8720904
  27. Nitric oxide and cardiac function.
    Circ Res. 1996 Sep;79(3):363-80 PMID: 8781470
  28. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
    N Engl J Med. 1996 Oct 10;335(15):1107-14 PMID: 8813041
  29. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem.
    Circulation. 1997 Jan 7;95(1):83-9 PMID: 8994421
  30. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression.
    J Biol Chem. 1997 Jan 10;272(2):1402-11 PMID: 8995451
  31. Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction.
    J Mol Cell Cardiol. 1997 Jan;29(1):1-9 PMID: 9040016
  32. Oral nitrates: more than symptomatic therapy in coronary artery disease?
    Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:213-8 PMID: 9211013
  33. Intravenous nitrates in the prehospital management of acute pulmonary edema.
    Ann Emerg Med. 1997 Oct;30(4):493-9 PMID: 9326864
  34. Sodium nitroprusside exacerbates myocardial ischemia-reperfusion injury.
    Ann Thorac Surg. 1997 Dec;64(6):1656-9; discussion 1659-60 PMID: 9436551
  35. Hibernation during hypoxia in cardiomyocytes. Role of mitochondria as the O2 sensor.
    J Biol Chem. 1998 Feb 6;273(6):3320-6 PMID: 9452449
  36. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection.
    Transplantation. 1998 Mar 27;65(6):804-12 PMID: 9539092
  37. The nitric oxide hypothesis of late preconditioning.
    Basic Res Cardiol. 1998 Oct;93(5):325-38 PMID: 9833145
  38. Nitric oxide: from discovery to the clinic.
    Trends Pharmacol Sci. 1998 Nov;19(11):436-8 PMID: 9850605
  39. Effect of ischemic preconditioning on myocardial oxygen consumption during ischemia.
    J Mol Cell Cardiol. 1998 Nov;30(11):2165-74 PMID: 9925354
  40. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
    Eur Heart J. 1999 Jan;20(1):51-7 PMID: 10075141
  41. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning.
    Circ Res. 1999 Mar 19;84(5):587-604 PMID: 10082480
  42. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption.
    Circ Res. 1999 Apr 16;84(7):840-5 PMID: 10205152
  43. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase.
    Am J Physiol. 1999 May;276(5 Pt 2):H1567-73 PMID: 10330240
  44. L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism.
    Am J Physiol. 1999 May;276(5 Pt 2):H1574-80 PMID: 10330241
  45. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.
    J Am Coll Cardiol. 1999 May;33(6):1506-11 PMID: 10334415
  46. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?
    Cardiovasc Res. 1999 Feb;41(2):385-94 PMID: 10341838
  47. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury.
    Ann N Y Acad Sci. 1999 Jun 30;874:354-70 PMID: 10415547
  48. Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts.
    Am J Cardiol. 1999 Aug 19;84(4A):27L-33L PMID: 10480443
Article Info
Journal
Heart (British Cardiac Society)
Abbr.
Heart
ISSN
1468-201X
DOI
10.1136/heart.86.4.368
Email
roby@rakhit.freeserve.co.uk
Published
2001-10-00
Pages
368-72
Language
English
Region
England
NLM ID
9602087
PMCID
PMC1729943
Subset
IM
External Links
PubMed source DOI: 10.1136/heart.86.4.368 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2